<DOC>
	<DOCNO>NCT01839448</DOCNO>
	<brief_summary>The main objective study estimate compare percentage patient abnormal glucose metabolism 4-12 week postpartum two group : patient diagnose gestational diabetes 24 week pregnancy . Abnormal glucose metabolism define type 2 diabetes , glucose intolerance impair fast glucose .</brief_summary>
	<brief_title>Abnormal Post-partum Glucose Metabolism After Gestational Diabetes Diagnosed Before After 24 Weeks Gestation</brief_title>
	<detailed_description>The secondary objective study compare two group : A. rate type 2 diabetes , glucose intolerance , impair fast glucose , patient require insulin 4-12 week postpartum B. rate maternal obstetric complication C. risk factor ( age , body mass index , personal history gestational diabetes macrosomia , first degree family history diabetes ) . D. For fast glucose do 24SA , calculate optimal threshold predict abnormal glucose metabolism immediate postpartum period among woman gestational diabetes .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>The patient must give inform sign consent The patient must insure beneficiary health insurance plan The patient available 10 month followup The patient pregnant consult 24 week amenorrhea AND least one follow risk factor : age &gt; 35 year ; body mass index &gt; 25 ; family history type 2 diabetes ; history gestational diabetes ; history macrosomia . The patient fast blood glucose level &gt; = 0.92 g/l 24 week amenorrhea OR fast blood glucose level &lt; 0.92 g/l 24 week amenorrhea AND abnormal oral glucose tolerance test ( 75 g glucose ) 24 28 week amenorrhea ( normal value set T0 &lt; 0.92 g/l ; T60 &lt; 1.80 g/l ; T120 &lt; 1.53 g/l ) . The patient participate another study The patient exclusion period determine previous study , exception follow study : Papillo PMA ( RCB 2013A0053837 ) , LXRs ( RCB 2009A0096849 ) , GrossPath ( RCB 2014A0112047 ) , BAKRI ( RCB 2013A0091441 ) , OASIS II ( RCB 2013A0077342 ) , ElastoMAP ( RCB 2013A0114837 ) , ElastoDéclench ( RCB 2014A0082839 ) UpSideDown ( RCB 2014A0192146 ) . The patient judicial protection , tutorship curatorship The patient refuse sign consent It impossible correctly inform patient The patient read French The patient known history type 2 diabetes The patient diagnose type 2 diabetes pregnancy ( fast blood glucose level &gt; 1.26 g/l ) The patient contraindication treatment necessary study The patient take chronic intermittent oral inhale corticosteroid , β2 agonist treatment previous disease disease discover pregnancy within one week precede fast glucose oral glucose tolerance test .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>post partum diabetes</keyword>
	<keyword>impaired fasting glucose</keyword>
</DOC>